MLchartDataset catalogue

Technetium Tc 99m hydroxydiphosphonate

Term · Oncology and biomedicine · MLC-T-ONC-017019

A radioconjugate containing hydroxydiphosphonate (HDP) labeled with the metastable radioisotope technetium Tc (99mTc), with radioimaging activity. Upon intravenous administration, skeletal uptake of technetium Tc-99m HDP occurs as a function of skeletal blood flow and osteogenic activity. HDP has a specific affinity for hydroxyapatite crystals in bone where abnormal accumulation of increased osteoid mineralization has occurred. Labeling of HDP with 99mTc allows gamma scintigraphic imaging of areas of abnormal osteogenesis associated with malignant bone lesions.

Table 1. Record
IdentifierMLC-T-ONC-017019
FieldOncology and biomedicine
AbbreviationTc-99m hydroxydiphosphonate
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017019",
  "term": "Technetium Tc 99m hydroxydiphosphonate",
  "field": "Oncology and biomedicine",
  "definition": "A radioconjugate containing hydroxydiphosphonate (HDP) labeled with the metastable radioisotope technetium Tc (99mTc), with radioimaging activity. Upon intravenous administration, skeletal uptake of technetium Tc-99m HDP occurs as a function of skeletal blood flow and osteogenic activity. HDP has a specific affinity for hydroxyapatite crystals in bone where abnormal accumulation of increased osteoid mineralization has occurred. Labeling of HDP with 99mTc allows gamma scintigraphic imaging of areas of abnormal osteogenesis associated with malignant bone lesions.",
  "abbreviation": "Tc-99m hydroxydiphosphonate",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/technetium-tc-99m-hydroxydiphosphonate/"
}

Record 16,072 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.